Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ovarian Suppression”

64 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 64 results

Testing effectiveness (Phase 2)Study completedNCT02344550
What this trial is testing

Study of GnRH-A [Leuprorelin(Lorelin Depot] Plus Leterozole +/- Everolimus for Premenopausal Women With Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Asan Medical Center 137
Testing effectiveness (Phase 2)Ended earlyNCT02452424
What this trial is testing

A Combination Clinical Study of PLX3397 and Pembrolizumab To Treat Advanced Melanoma and Other Solid Tumors

Who this might be right for
MelanomaNon-small Cell Lung CancerSquamous Cell Carcinoma of the Head and Neck+2 more
Daiichi Sankyo 78
Early research (Phase 1)Looking for participantsNCT07310420
What this trial is testing

A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer

Who this might be right for
Advanced Breast CancerEarly Breast Cancer
TerSera Therapeutics LLC 176
Not applicableLooking for participantsNCT06611072
What this trial is testing

OveRcoming immunosupprEssion aNd rebAlancing the Immune reSponSe in ovAriaN CancEr Study

Who this might be right for
Ovarian NeoplasmsOvarian CancerOvarian Carcinoma+2 more
Gynaecologisch Oncologisch Centrum Zuid 90
Not applicableLooking for participantsNCT06606535
What this trial is testing

ENDO-BRAIN: Effects of Endocrine Adjuvant Therapy with Aromatase Inhibitors on the Cognitive Function of Breast Cancer Patients

Who this might be right for
Cognitive Side Effects of Cancer TherapyHypoestrogenism
Ospedale Policlinico San Martino 60
Not applicableUnknownNCT01421797
What this trial is testing

Evaluation of Adrenal Androgens in Normal and Obese Girls After Suppression and Stimulation

Who this might be right for
HyperandrogenemiaPolycystic Ovary SyndromeObesity
University of Virginia 84
Very early researchWithdrawnNCT01422733
What this trial is testing

Effect of Longer-term Adrenal Suppression Using Low Dose Hydrocortisone on Androgen Overproduction

Who this might be right for
HyperandrogenemiaObesityPolycystic Ovary Syndrome
University of Virginia
Not applicableUnknownNCT06304220
What this trial is testing

Comparison of Two PPOS Models for Pituitary Suppression

Who this might be right for
Infertility, FemaleFertility Disorders
NextFertility 210
Testing effectiveness (Phase 2)Study completedNCT01105650
What this trial is testing

Allogeneic Natural Killer (NK) Cells for Ovarian, Fallopian Tube, Peritoneal and Metastatic Breast Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer+1 more
Masonic Cancer Center, University of Minnesota 13
Testing effectiveness (Phase 2)Study completedNCT00429494
What this trial is testing

GnRH Analogue for Ovarian Function Preservation in Hematopoietic Stem Cell Transplantation Patients

Who this might be right for
AmenorrheaPremature Ovarian FailureOvarian Function Insufficiency
M.D. Anderson Cancer Center 60
Not applicableEnded earlyNCT01428193
What this trial is testing

Effects of Androgen Blockade on Sensitivity of the GnRH Pulse Generator to Suppression by Estradiol and Progesterone

Who this might be right for
Polycystic Ovary SyndromeHyperandrogenism
University of Virginia 4
Testing effectiveness (Phase 2)Study completedNCT02550977
What this trial is testing

Russia/Ukraine Suppression of Ovarian Activity Study

Who this might be right for
Contraception
Bayer 91
Testing effectiveness (Phase 2)Looking for participantsNCT07158021
What this trial is testing

Leuprolide and Goserelin for Ovarian Function Suppression in Pre- or Peri-menopausal Women With Breast Cancer, OFS Trial

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8+2 more
University of Michigan Rogel Cancer Center 75
Not applicableStudy completedNCT01928186
What this trial is testing

FLT PET in Measuring Treatment Response in Patients With Newly Diagnosed Estrogen Receptor-Positive, HER2-Negative Stage I-III Breast Cancer

Who this might be right for
Estrogen Receptor PositiveHER2/Neu NegativeMale Breast Carcinoma+7 more
University of Washington 28
Testing effectiveness (Phase 2)Active Not RecruitingNCT07096583
What this trial is testing

An Exploratory Study on NK Cell-assisted Prevention of Bone Marrow Suppression During Chemotherapy for Ovarian Cancer

Who this might be right for
Ovary Cancer
Anhui Provincial Cancer Hospital 20
Not applicableLooking for participantsNCT07128394
What this trial is testing

Extra Luteinizing Hormone Improve Embryo Quality in IVF Patients With Low LH During Long GnRH-Agonist Treatment

Who this might be right for
Infertility, FemaleLuteinizing Hormone (LH)
Nanjing University 590
Large-scale testing (Phase 3)Looking for participantsNCT05879926
What this trial is testing

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Who this might be right for
Breast Cancer
NRG Oncology 3,960
Not applicableLooking for participantsNCT05910294
What this trial is testing

Prevent and Improve Sexual Health Concerns for People With Breast Cancer

Who this might be right for
Improve Sexual HealthImprove Vulvovaginal Health
Memorial Sloan Kettering Cancer Center 50
Not applicableUnknownNCT05801705
What this trial is testing

Comparative Evaluation of Efficacy and Safety of Toremifene, Tamoxifen, and Aromatase Inhibitor Plus Ovarian Function Suppression in Hormone Receptor-Positive Early Breast Cancer Among Non-Low-Risk Premenopausal Women: A Real-World Study

Who this might be right for
Hormone-receptor-positive Breast CancerPremenopausal Breast CancerBreast Cancer Patients at Intermediate to High Risk+1 more
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 700
Very early researchWithdrawnNCT01422707
What this trial is testing

Effect of Short Term Adrenal Suppression on Androgen Overproduction in Overweight Girls With Androgen Excess

Who this might be right for
HyperandrogenemiaObesityPolycystic Ovary Syndrome
University of Virginia
Next Page